Levitra Maker Says SCC Are Wrong
Written by Rupert Kircz | Thursday, 21 January 2010 | There is 1 comment
The manufacturer of the erectile dysfunction medication Levitra has put out a statement saying that it will definitely appeal the legal ruling issued by the Swiss Competition Commission regarding the alleged price fixing scam surrounding the drugs Viagra, Cialis and Levitra.

The Swiss arm of Bayer vehemently denied any participation in the fixing of prices and said the price of the Levitra drug had been decided without any consultation with Pfizer who make Viagra and Eli Lilly who make Cialis. They specifically said that they did not “make any agreements or have any discussions” with either pharmacies who sold Levitra or with doctors who were prescribing it and that they therefore were completely within Swiss competition law.
The Swiss Competition Commission have fined the three erectile dysfunction drug manufacturers almost 6 million Swiss Francs after they said there was evidence that the prices had been the result of a collaboration which was detrimental to the public.
Pfizer have already implied that they will appeal the decision but Eli Lilly has not committed itself to any legal appeal. It looks like this case could drag on for years as it goes through the Swiss legal system. This case has shocked the medical establishment in the normally staid Switzerland and has made many people suspicious of large pharmaceutical companies.
Price fixing is a very serious crime in most European countries and is thought to be particularly despicable by the public when it comes to medication. While many people may think that getting men to pay a little bit more for erectile dysfunction medication is not such a serious thing it should be dealt with quickly and effectively because should it start to permeate into lifesaving medications such as cancer or heart disease drugs things could get very ugly in the world of big Pharma.


